Maneesh Pharmaceuticals Limited — Strip Exporter Profile
Indian Pharmaceutical Exporter · #2 for Strip · $1.7M export value · DGFT Verified
Maneesh Pharmaceuticals Limited is the #2 Indian exporter of Strip with $1.7M in export value and 34 verified shipments. Maneesh Pharmaceuticals Limited holds a 0.9% market share in Strip exports across 6 countries. The company exports 6 pharmaceutical products worth $31.9M across 4 therapeutic categories.
Maneesh Pharmaceuticals Limited — Strip Export Profile: Buyers & Destinations
Where Does Maneesh Pharmaceuticals Limited Export Strip?
| Country | Value | Shipments | Share |
|---|---|---|---|
| INDONESIA | $800.0K | 16 | 47.1% |
| NIGERIA | $500.0K | 10 | 29.4% |
| MYANMAR | $100.0K | 2 | 5.9% |
| CHINA | $100.0K | 2 | 5.9% |
| PAPUA NEW GUINEA | $100.0K | 2 | 5.9% |
| KENYA | $100.0K | 2 | 5.9% |
Maneesh Pharmaceuticals Limited exports Strip to 6 countries. The largest destination is INDONESIA accounting for 47.1% of Maneesh Pharmaceuticals Limited's Strip shipments, followed by NIGERIA (29.4%) and MYANMAR (5.9%). These destinations reflect Maneesh Pharmaceuticals Limited's established distribution network and regulatory approvals in key markets.
Who Are the Top Buyers of Strip from Maneesh Pharmaceuticals Limited?
| Buyer | Country | Value | Orders |
|---|---|---|---|
| NATIONAL TUBERCULOSIS AND LEPROSY | NIGERIA | $500.0K | 10 |
| SEKRETARIAT DITJEN PENCEGAHAN DAN P | INDONESIA | $400.0K | 8 |
| DR TIFFANY TIARA PAKASI | INDONESIA | $200.0K | 4 |
| UNOPS | MYANMAR | $100.0K | 2 |
| SEKRETARIAT DITJEN PENCEGAHAN | INDONESIA | $100.0K | 2 |
| SEKRET ARIAT DITJEN PENCEGAHAN | INDONESIA | $100.0K | 2 |
| WHO REPRESENTATIVE WHO COUNTRY OFFICE | CHINA | $100.0K | 2 |
| UNOPS PNG OFFICE | PAPUA NEW GUINEA | $100.0K | 2 |
| KENYA MEDICAL SUPPLIES AGENCY | KENYA | $100.0K | 2 |
Maneesh Pharmaceuticals Limited supplies Strip to 9 buyers globally. The largest buyer is NATIONAL TUBERCULOSIS AND LEPROSY (NIGERIA), followed by SEKRETARIAT DITJEN PENCEGAHAN DAN P (INDONESIA) and DR TIFFANY TIARA PAKASI (INDONESIA). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.
What Is India's Total Strip Export Value and How Much Does Maneesh Pharmaceuticals Limited Contribute?
India exported $140.4M worth of Strip through 15,000 shipments from 612 suppliers to 170 countries, serving 2,109 buyers globally. Maneesh Pharmaceuticals Limited contributes $1.7M to this total, accounting for 0.9% of India's Strip exports. Maneesh Pharmaceuticals Limited ships Strip to 6 countries through 9 buyers.
What Is the Average Shipment Value for Maneesh Pharmaceuticals Limited's Strip Exports?
Maneesh Pharmaceuticals Limited's average Strip shipment value is $50.0K per consignment, based on 34 shipments totaling $1.7M. The largest destination is INDONESIA (47.1% of Maneesh Pharmaceuticals Limited's Strip exports).
How Does Maneesh Pharmaceuticals Limited Compare to Other Indian Strip Exporters?
Maneesh Pharmaceuticals Limited ranks #2 among 612 Indian Strip exporters with a 0.9% market share. The top 3 exporters are SUN PHARMACEUTICAL INDUSTRIES LIMITED ($119.8M), SUN PHARMACEUTICAL INDUSTRIES LTD ($5.8M), SRS PHARMACEUTICALS PRIVATE LIMITED ($2.7M). Maneesh Pharmaceuticals Limited processed 34 shipments to 6 destination countries.
What Strip Formulations Does Maneesh Pharmaceuticals Limited Export?
| Product Description / Formulation | Value | Shipments |
|---|---|---|
| 6 STRIPS OF 28 TABLETS EACH OF RIFAMPICI | $500.0K | 10 |
| 12 STRIPS OF 28 TABLETS EACH OF RIFAMPIC | $450.0K | 9 |
| 6 STRIPS OF 28 TABLETS EACH OF RIFAMPICIN 150 MG/ISONIAZID 75 MG/PYRAZINAMIDE 400MG/ETHAMBUTOL HCL 275MG TABLETS(25602 CNOS | $150.0K | 3 |
| 12 STRIPS OF 28 TABLETS EACH OF RIFAMPICIN 150 MG/ ISONIAZID 75 MG TABLETS (25602 CARTONS)NOS | $150.0K | 3 |
| 12 STRIPS OF 28 TABLETS EACH OF RIFAMPI | $50.0K | 1 |
| 12 STRIPS OF 28 TABLETS EACH OF RIFAMPICIN 150 MG/ ISONIAZID 75 MG TABLETS -11870x12=142440 strips | $50.0K | 1 |
| 6 STRIPS OF 28 TABLETS EACH OF RIFAMPICIN 150 MG/ ISONIAZID 75 MG / PYRAZINAMIDE400MG / ETHAMBUTOL 275MG TABLETS- 1187 | $50.0K | 1 |
| 6 STRIPS OF 28 TABLET EACH OF RIFAMPICIN150MG+ISONIAZID 75MG+PYRAZINAMIDE 400MG+ETHAMBUTOL HCL 275MG TABLET-20000X6TABS | $50.0K | 1 |
| 12 STRIPS OF 28 TABLETS EACH OF RIFAMPICIN 150 MG + ISONIAZID 75 MG TABLETS - 20000X12 TABS | $50.0K | 1 |
| 6 STRIPS OF 28 TABLETS EACH OF RIFAMPICIN 150 MG/ISONIAZID 75 MG/PYRAZINAMIDE 400MG/ETHAMBUTOL HCL 275MG TABLETS(25250 C | $50.0K | 1 |
Maneesh Pharmaceuticals Limited exports 13 distinct Strip formulations including tablets, capsules, syrups, and combination drugs. The top formulation is 6 STRIPS OF 28 TABLETS EACH OF RIFAMPICI with 10 shipments worth $500.0K.
Regulatory Requirements: Exporting Strip to Key Markets
What Maneesh Pharmaceuticals Limited must comply with to export Strip to its top destination countries
Nigeria — NAFDAC
Approval Process
Drug registration under NAFDAC guidelines. WHO-type CPP from India required.
Timeline: 6–18 months
GMP & Export Requirements
WHO GMP compliance; NAFDAC conducts overseas plant inspections
Certificate of Pharmaceutical Product (CPP) from CDSCO India; NAFDAC import permit
Note: India is the largest pharma supplier to Nigeria. NAFDAC has intensified Indian site inspections.
Regulatory information is provided for general reference based on publicly available guidelines. Requirements vary by formulation, dosage form, and therapeutic classification. Exporters should consult qualified regulatory affairs professionals for case-specific guidance.
How Does Maneesh Pharmaceuticals Limited Compare to Nearest Strip Exporters?
Exporters ranked immediately above and below #2 by export value
| # | Supplier | Export Value | Shipments | Countries | Avg/Shipment |
|---|---|---|---|---|---|
| 8 | GUFIC BIOSCIENCES LIMITED | $1.9M | 72 | 6 | $26.4K |
| 5 | SVIZERA LABS PRIVATE LIMITED | $1.8M | 35 | 2 | $50.0K |
| 2 | MANEESH PHARMACEUTICALS LIMITED ★ | $1.7M | 34 | 6 | $50.0K |
| 3 | AP WAREHOUSING AND TRADING LLP | $1.4M | 28 | 1 | $50.0K |
| 9 | ZYDUS LIFESCIENCES LIMITED | $1.3M | 46 | 5 | $27.2K |
Maneesh Pharmaceuticals Limited ranks #2 among 612 Indian Strip exporters. Average shipment value of $50.0K compared to the market average of $229.4K. The closest competitors by value are GUFIC BIOSCIENCES LIMITED and SVIZERA LABS PRIVATE LIMITED.
Which Indian Ports Ship Strip Exports?
| Port | Shipments | % Share |
|---|---|---|
| SAHAR AIR CARGO ACC (INBOM4) | 3,252 | 21.7% |
| SAHAR AIR | 2,848 | 19.0% |
| Bombay Air Cargo | 714 | 4.8% |
| NHAVA SHEVA SEA (INNSA1) | 701 | 4.7% |
| DELHI AIR | 672 | 4.5% |
| DHANNAD ICD | 615 | 4.1% |
| Bombay Air | 577 | 3.8% |
| DELHI AIR CARGO ACC (INDEL4) | 483 | 3.2% |
Geopolitical & Trade Policy Impact on Maneesh Pharmaceuticals Limited's Strip Exports
The current geopolitical climate presents both challenges and opportunities for Indian pharmaceutical exporters like Maneesh Pharmaceuticals. The Israel-Iran tensions have led to disruptions in Red Sea shipping routes, resulting in increased shipping costs and extended transit times. Major shipping lines have implemented 'Emergency Risk Surcharges' ranging from $250 to $500 per TEU, directly impacting the cost structures of exporters relying on these routes. (sgeexport.com)
Conversely, the US-China trade tensions have prompted the United States to seek alternative sources for pharmaceutical imports, potentially benefiting Indian exporters. However, the imposition of tariffs on pharmaceutical imports by the US poses a risk. While Indian generics have largely remained exempt, any expansion of tariffs could adversely affect companies like Maneesh Pharmaceuticals, which rely on the US market for a significant portion of their exports. (pharma.economictimes.indiatimes.com)
The recent India-European Union Free Trade Agreement (FTA), signed on January 27, 2026, offers a favorable development. The FTA eliminates tariffs on Indian pharmaceutical products entering the EU, providing Maneesh Pharmaceuticals with enhanced access to European markets. This agreement is expected to boost India's pharmaceutical exports to the EU, presenting growth opportunities for the company. (en.wikipedia.org)
Maneesh Pharmaceuticals Limited — Regulatory Compliance & Quality Standards
Compliance with international regulatory standards is paramount for Indian pharmaceutical exporters. The US Food and Drug Administration (FDA), World Health Organization (WHO), and European Union Good Manufacturing Practices (EU GMP) set stringent quality requirements. Indian companies have faced increased scrutiny, leading to higher compliance costs and, in some cases, reduced export volumes. (transdatanexus.com)
For Maneesh Pharmaceuticals, maintaining adherence to these evolving standards is crucial to sustain and expand its export markets. Continuous investment in quality assurance and regulatory compliance will be essential to navigate the complex global regulatory environment and to meet the expectations of international partners and consumers.
About Maneesh Pharmaceuticals Limited
Maneesh Pharmaceuticals Limited exports 6 products worth $31.9M. Beyond Strip, top products include Rifampicin, Isoniazid, Ethambutol, Pyrazinamide, Primaquine. View the complete Maneesh Pharmaceuticals Limited profile for full portfolio analysis.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Strip — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Strip shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
- 2.Supplier Identification: Maneesh Pharmaceuticals Limited matched across shipments using name normalization, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
- 4.Verified Records: This page is backed by 34 individual customs records matching Maneesh Pharmaceuticals Limited exporting Strip, covering 13 formulations to 6 countries via 9 buyers.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 170+ countries, 2,109+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Strip Export Data from Maneesh Pharmaceuticals Limited
Access shipment-level details, pricing data, buyer connections, and competitive analysis for Maneesh Pharmaceuticals Limited's Strip exports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
Maneesh Pharmaceuticals Limited
Full Company Profile →
6 products · $31.9M total trade · 4 categories
Strip Stats
Company Overview
Top Products by Maneesh Pharmaceuticals Limited
Related Analysis
Need Detailed Export Data?
Access shipment-level records, pricing trends, and buyer contacts for Maneesh Pharmaceuticals Limited.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Strip. For current shipment-level data, contact TransData Nexus.